MERCURYLAB
Mercury Laboratories financials
- Market cap
- ₹91 Cr
Quarterly results
Q1 FY27: revenue down 12.0%, net profit down 69.1% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 18 | 20 | 21 | 18 | 19 +5% | 18 −6% | 20 −1% | 16 −12% |
| EBITDA | 1 | 2 | 2 | 2 | 2 +63% | 3 +27% | 2 −4% | 1 −50% |
| Net profit | 1 | 1 | 1 | 1 | 2 +228% | 1 −16% | 1 +11% | 0 −69% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −6.8% 1Y
1Y: ₹858.15 on 9 Sept 2025 → ₹799.8. High ₹906.95 (10 Oct 2025), low ₹700 (30 Mar 2026).
Financials, as filed
Revenue grew 0.3% a year over 2 years, FY24 to FY26. Operating margin held at 11.9%.
| Year ending | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹76 Cr | ₹75 Cr | ₹76 Cr |
| Operating profit | ₹9 Cr | ₹7 Cr | ₹9 Cr |
| Operating margin | 12.0% | 9.4% | 11.9% |
| Interest | ₹0 Cr | ₹1 Cr | ₹1 Cr |
| Depreciation | ₹3 Cr | ₹3 Cr | ₹3 Cr |
| Net profit | ₹6 Cr | ₹3 Cr | ₹5 Cr |
| Net margin | 7.5% | 4.2% | 6.4% |
| Cash from operations | ₹8 Cr | ₹4 Cr | ₹4 Cr |
| Free cash flow | ₹2 Cr | ₹-5 Cr | ₹1 Cr |
| ROCE | 13.4% | 8.9% | 12.1% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| Reserves | ₹36 Cr | ₹39 Cr | ₹44 Cr | ₹50 Cr | ₹55 Cr | ₹57 Cr |
| Borrowings | ₹7 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹8 Cr |
| Other liabilities | ₹21 Cr | ₹16 Cr | ₹13 Cr | ₹12 Cr | ₹12 Cr | ₹13 Cr |
| Total liabilities | ₹65 Cr | ₹62 Cr | ₹64 Cr | ₹68 Cr | ₹74 Cr | ₹79 Cr |
| Fixed assets | ₹26 Cr | ₹26 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr |
| Capital work in progress | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹4 Cr | ₹9 Cr | ₹10 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other assets | ₹39 Cr | ₹37 Cr | ₹40 Cr | ₹40 Cr | ₹41 Cr | ₹45 Cr |
| Total assets | ₹65 Cr | ₹62 Cr | ₹64 Cr | ₹68 Cr | ₹74 Cr | ₹79 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
The ownership split has held steady since Jun 2025. The shareholder count shrank 4% to 1,328.
- Promoters
- 73.7%
- Public
- 26.3%
Since Jun 2025
- Promoters 0.00 pp
- Public 0.00 pp
How it drifted, 12 quarters
Ownership split by quarter, oldest first. Sep '23: Promoters 73.7%, Public 26.3%.Dec '23: Promoters 73.7%, Public 26.4%.Mar '24: Promoters 73.7%, Public 26.3%.Jun '24: Promoters 73.7%, Public 26.4%.Sep '24: Promoters 73.7%, Public 26.4%.Dec '24: Promoters 73.7%, Public 26.3%.Mar '25: Promoters 73.7%, Public 26.3%.Jun '25: Promoters 73.7%, Public 26.3%.Sep '25: Promoters 73.7%, Public 26.3%.Dec '25: Promoters 73.7%, Public 26.4%.Mar '26: Promoters 73.7%, Public 26.3%.Jun '26: Promoters 73.7%, Public 26.3%.
Who is on the register
Named in the Jun 2026 filing
Every holder of Mercury Laboratories Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Shah Dilip Ramanlal HUF | 25.88% | unchanged |
| Shah Rajendra Ramanlal Huf | 17.42% | unchanged |
| Janki Rajendra Shah | 8.67% | unchanged |
| Rajendra Ramanlal Shah | 7.14% | unchanged |
| Dilip Ramanlal Shah | 7.07% | unchanged |
| Investor Education And Protection Fund Authority Ministry Of Corporate Affairs | 6.40% | unchanged |
| Rajeshri Ketan Shah | 2.20% | unchanged |
| Paresh Ramanlal Shah | 1.97% | unchanged |
| Kaumudini Rajendra Shah | 1.76% | unchanged |
| Bharati Bharat Dattani | 1.64% | unchanged |
| Jeet Ketan Shah | 1.31% | unchanged |
| Adit Dilipbhai Shah | 1.29% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse Mercury Laboratories Limited
Guides on how to read this kind of business and the numbers that matter.